Login / Signup

Publisher Correction: Adjuvant nivolumab in resected stage IIB/C melanoma: primary results from the randomized, phase 3 CheckMate 76K trial.

Joanne M JeterMichele Del VecchioJeffrey WeberChristoph HoellerJean-Jacques GrobPeter MohrCarmen LoquaiCaroline DutriauxVanna Chiarion-SileniJacek MackiewiczPiotr RutkowskiPetr ArenbergerGaelle QuereuxTarek M MeniawyPaolo Antonio AsciertoAlexander M MenziesPiyush DuraniMaurice LoboFederico CampigottoBrian GastmanGeorgina V Long
Published in: Nature medicine (2023)
Keyphrases
  • phase iii
  • phase ii
  • open label
  • double blind
  • clinical trial
  • placebo controlled
  • early stage
  • study protocol
  • lymph node
  • skin cancer
  • prognostic factors
  • randomized controlled trial